Prevention of Prescription Opioid Drug Abuse and Misuse—Prescription Drug Monitoring Programs
In this series of reviews, OIG reviewed actions that selected States have taken, using Federal funds for enhancing prescription drug monitoring programs (PDMPs), to achieve program goals toward improving safe prescribing practices and preventing prescription drug abuse and misuse. OIG also determined whether the States complied with certain Federal requirements. This series includes States that have had a high number of overdose deaths, have had a significant increase in the rate of drug overdose deaths, or have received HHS funding to enhance their PDMPs.
Last Updated April 26, 2024
California
- California Made Progress Toward Achieving Program Goals for Enhancing Its Prescription Drug Monitoring Program (A-09-18-01006)
Kentucky
- The University of Kentucky Made Progress Toward Achieving Program Goals for Enhancing Its Prescription Drug Monitoring Program (A-04-18-02012)
New York
- New York Achieved Program Goals For Enhancing Its Prescription Drug Monitoring Program (A-02-18-02001)
Ohio
- Ohio Made Progress Toward Achieving Program Goals for Enhancing Its Prescription Drug Monitoring Program (A-05-18-00004)